| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/20/2004 | US20040097457 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
| 05/20/2004 | US20040097425 Peptide compounds |
| 05/20/2004 | US20040097423 Anticancer agents; antiproliferative agents; therapy for drug resistant cancer |
| 05/20/2004 | US20040097421 Melphalan derivatives and their use as cancer chemotherapeutic drugs |
| 05/20/2004 | US20040097413 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 05/20/2004 | US20040097412 Non-mammalian GnRH analogs and uses thereof in tumor cell growth regulation and cancer therapy |
| 05/20/2004 | US20040097408 Anticancer agents |
| 05/20/2004 | US20040097407 Method for the synthesis of compounds of formula I and their uses thereof |
| 05/20/2004 | US20040097403 Linkable sialyl lewis x analogs |
| 05/20/2004 | US20040096921 Human plasma hyaluronidase |
| 05/20/2004 | US20040096916 Using peptides and aberrant cell surface proteins for diagnosis, prognosis and identification of subtpyes of kidney cell tumors |
| 05/20/2004 | US20040096888 Comprises nucleotide sequences coding cyclin dependent kinase (PELOTA) for diagnosis, treatment, prognosis and prevention of cell proliferative, cardoivascular, inflammatory, arthritic disorders |
| 05/20/2004 | US20040096881 For prophylactics/diagnostics/therapeutics; endothelial nitric oxide synthase (eNOS) |
| 05/20/2004 | US20040096877 For diagnosis/treatment/prevention of inflammation/asthma/ allergies |
| 05/20/2004 | US20040096868 For diagnosis/treatment of cancer; drugs; kits; cell-free analysis; solid phase synthesis |
| 05/20/2004 | US20040096848 Oligomeric compounds for the modulation HIF-1alpha expression |
| 05/20/2004 | US20040096841 Novel polypeptide-phosphatidic acid phsphatase 29.81 and the polynucleotide encoding said polypeptide |
| 05/20/2004 | US20040096815 Comprises compared proteomic and/or compared transcriptomic and/or compared genomic analysis; enzyme-linked immunosorbent assay (ELISA) |
| 05/20/2004 | US20040096526 Using plant extracts mixtures; extraction, filtration, spray drying; beverages |
| 05/20/2004 | US20040096518 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/20/2004 | US20040096517 Drug obtained from reverse chromatography of human urine; extraction; purification |
| 05/20/2004 | US20040096502 Pharmaceutical pellets comprising tamsulosin |
| 05/20/2004 | US20040096465 Novel receptors for $1(helicobater pyroli) and use thereof |
| 05/20/2004 | US20040096452 Multivalent vaccines for the treatment of B-cell malignancies (e.g., lymphomas and leukemias) . The present invention also provides methods for the production of custom vaccines, including multivalent vaccines for the treatment of immune |
| 05/20/2004 | US20040096450 Determining the prophylactic suitability and quality control of compositions, such as intravenous immunoglobulin mixtures and Fac proteins for use in such methods, of preparing compositions for treating such disorders. |
| 05/20/2004 | US20040096442 Modified anti-egfr antibodies with reduced immunogenicity |
| 05/20/2004 | US20040096436 Method for treating cancer comprising administering to a subject in need of such treatment a therapeutically effective amount of a member selected from an inhibitor of a protein kinase, an enantiomer of such a compound, a prodrug of such a |
| 05/20/2004 | US20040096435 Methods for screening compounds that modulate lipid metabolism |
| 05/20/2004 | US20040096426 Compositions and methods for identifying antigens which elicit an immune response |
| 05/20/2004 | US20040096425 Method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosensitising agent, the cell is irradiated with light of a wavelength effective to activate the photosensitising agent and, substantially at the |
| 05/20/2004 | US20040096393 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain) |
| 05/20/2004 | US20040093795 Floral packaging material having great masters prints thereon |
| 05/20/2004 | CA2412414A1 Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof |
| 05/19/2004 | EP1420027A2 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds |
| 05/19/2004 | EP1420022A1 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 05/19/2004 | EP1420019A1 Substituted pyridino pentaazamacrocyle ligands having superoxide dismutase activity |
| 05/19/2004 | EP1420011A1 Compounds usefulfor treating allergic and inflammatory diseases |
| 05/19/2004 | EP1419784A2 Proteosome vaccines against toxins, allergy and cancer |
| 05/19/2004 | EP1419782A1 Use of consensus interferon for reducing the side-effects of interferon treatment in viral hepatitis |
| 05/19/2004 | EP1419779A1 Pharmaceutical composition inducing cancer cell differentiation and their use for treatment and prevention of cancer |
| 05/19/2004 | EP1419778A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/19/2004 | EP1419394A2 Modulation of steroid hormone uptake |
| 05/19/2004 | EP1419393A1 Tumor specific oligosaccharide sequences and use thereof |
| 05/19/2004 | EP1419264A2 Kinases and phosphatases |
| 05/19/2004 | EP1419257A1 Methylation resistant vectors |
| 05/19/2004 | EP1419256A2 Conjugates for the modulation of immune responses |
| 05/19/2004 | EP1419249A2 TIMM8b-RELATED PROTEIN |
| 05/19/2004 | EP1419241A2 Improved nitroreductase enzymes |
| 05/19/2004 | EP1419178A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 05/19/2004 | EP1419177A2 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 05/19/2004 | EP1419166A2 Platinum(ii)- and platinum(iv)-complexes and their use |
| 05/19/2004 | EP1419159A1 1-alkyl 0r 1-cycloalkyltriazolo 4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
| 05/19/2004 | EP1419158A1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 05/19/2004 | EP1419157A2 HETEROCYCLIC COMPOUND BASED ON N sp 6 /sp −SUBSTITUTED ADENINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE |
| 05/19/2004 | EP1419154A1 Rapamycin 29-enols |
| 05/19/2004 | EP1419153A1 Rapamycin dialdehydes |
| 05/19/2004 | EP1419151A1 Chrystals including a malic acid salt of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indole-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
| 05/19/2004 | EP1419150A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 05/19/2004 | EP1419143A1 24-sulfur-substituted analogs of 1alpha,25-dihydroxy vitamin d3 |
| 05/19/2004 | EP1418949A2 Inhibitor of dna methylation |
| 05/19/2004 | EP1418947A1 Pharmaceutical compositions comprising polysaccharide conjugates for inhibiting the metastasis or preventing the recurrence of malignant tumor |
| 05/19/2004 | EP1418936A2 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 05/19/2004 | EP1418931A1 New drug |
| 05/19/2004 | EP1418926A2 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and their use in bone marrow transplantation |
| 05/19/2004 | EP1418921A1 Anti-tumour 2-alkoxyestradiol sulfamates |
| 05/19/2004 | EP1418919A2 The use of 5 fluorourcil, delivered by inotophoresis as an inhibitor of cell proliferation in the eye, bulbar and palpebral conjunctiva, eyelid, peri-orbital soft tissues and skin |
| 05/19/2004 | EP1418917A1 Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
| 05/19/2004 | EP1418916A1 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer |
| 05/19/2004 | EP1418915A1 Neuroprotective drug |
| 05/19/2004 | EP1418911A1 2,4,5-trisubstituted thiazolyl derivatives ant their antiinflammatory activity |
| 05/19/2004 | EP1418909A2 2-amino-4, 5-trisubstituted thiaolyl derivatives and their use against autoimmune diseases |
| 05/19/2004 | EP1418900A1 Selective estrogen receptor modulators |
| 05/19/2004 | EP1418899A1 Medicament which can be used for the treatment of cancer |
| 05/19/2004 | EP1418897A2 Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer |
| 05/19/2004 | EP1259505B1 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same |
| 05/19/2004 | EP1250334B1 Medicaments useful for the treatment of proliferative diseases |
| 05/19/2004 | EP1235824B1 Vitamin d analogues |
| 05/19/2004 | EP1229936B1 Use of anti-idiotypical antibodies as vaccines against cancer |
| 05/19/2004 | EP1220855B1 Anhydrous salt |
| 05/19/2004 | EP1064294B1 5-imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them |
| 05/19/2004 | EP1017810B1 Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
| 05/19/2004 | EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/19/2004 | EP1007551B1 Vaccine against hpv |
| 05/19/2004 | EP1000051B1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/19/2004 | EP0960123A4 Sprouty protein and coding sequence |
| 05/19/2004 | EP0941227B1 Epothilone d, production process, and its use as cytostatic as well as phytosanitary agent |
| 05/19/2004 | EP0781136B1 Compounds and methods for the treatment of cancer |
| 05/19/2004 | EP0711173B1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 05/19/2004 | DE60100389T2 Fettlösliche Substanzen enthaltende Granulate und Verfahren zu ihrer Herstellung Fat-soluble substances containing granules, and processes for their preparation |
| 05/19/2004 | DE60003103T2 Substituierte dimere Verbindungen Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen Substituted dimeric compounds process for their preparation and their pharmaceutical compositions |
| 05/19/2004 | DE10251028A1 Verwendung von Progesteron oder einem Progesteronrezeptor-Agonisten zur Hemmung der Steroidsynthese Use of progesterone or a progesterone receptor agonists for the inhibition of steroid synthesis |
| 05/19/2004 | CN1498237A Process for preparing lactic acid oligomer |
| 05/19/2004 | CN1498225A Template-fixed peptidomimetics with antimicrobial activity |
| 05/19/2004 | CN1498217A Heterocyclic compounds for aging-related and diabetic vascular complications |
| 05/19/2004 | CN1498212A New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 05/19/2004 | CN1498206A Biurethane derivatives |
| 05/19/2004 | CN1498115A Hydroxyalkyl starch-active agent-conjugate |
| 05/19/2004 | CN1498112A Combination therapy for estrogen-dependent disorders |
| 05/19/2004 | CN1498107A Combination of taxane and cyclin-dependent kinase inhibitor |
| 05/19/2004 | CN1498106A Pharmaceutical forms of epothilones for oral administration |